肝病是影響人類健康的重要因素之一，而肝癌也一直位居癌症十大死因前一、二名。脂肪肝是肝病的一種，而台灣在患脂肪肝的人口比例上竟然位居世界之首。1脂肪肝的患者如果不做規劃性或藥物性的控制，有很大的機率會惡化成脂肪肝炎或是肝硬化。脂肪肝的重要性吸引了許多學者投入研究，希望能對這個病症的治療或預防有更多的貢獻。
在我的研究之中，我主要結合了多光子顯微術、本實驗室自製的肝觀察視窗平台、與螢光劑6-CFDA來進行活體實驗。非螢光性的6-CFDA會在肝細胞內被分解成發螢光的6-CF，然後被肝細胞的蛋白質運輸出去，我們利用6-CF在肝細胞內的強度變化來估計肝細胞的代謝能力。另外我使用的動物模型是餵食MCD的B57CL/6小鼠，分別在餵食後的第二、四、六、八個禮拜做實驗，實驗結果與控制組老鼠比較顯示患脂肪肝會造成肝表現較差的代謝能力。

Liver disease represent a major health problem worldwide. Fatty liver is a common liver disease which can progress to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis. In this thesis, in order to elucidate the effects of fatty liver on hepatobiliary metabolism, we combined multi-photon microscopy with a home-built intravital hepatic imaging chamber (IHIC) to image and quantify the metabolic capacity of liver in methionine- and choline-deficient (MCD) dietary animal model. Mice were imaged at 2, 4, 6, and 8 weeks after they were first fed with MCD. Non-fluorescent 6-carboxyfluorescein diacetate (6-CFDA) which is hydrolyzed by the hepatocytes into fluorescent 6-carboxyfluorescein (6-CF) and excreted into the bile canaculi by the multidrug resistant proteins (mrps) is then used as the molecular probe in tracing the effects of fatty liver on hepatobiliary metabolism. Our data showed that the metabolic function of liver in fatty liver diseased mice is impaired in comparison with that of normal mice.

Abstract ii
摘要 iii
Figure Catalog iv
Table catalog v
Chapter 1 Introduction 1
Chapter 2 Basic Principles 3
2.1 Two-Photon Excitation 3
2.2 Principles of Optical Microscopy 9
2.3 First-Order Kinetic Model for Hepatobiliary Metabolism 12
Chapter 3 Liver Organization and the Fatty Liver Disease 14
3.1 Liver Structure and Functions 14
3.1.1 Hepatobliary Circulation 14
3.1.2 Structure of Liver 16
3.2 Lipid Metabolism 19
3.3 Introduction to NAFLD 21
Chapter 4 Materials and Methods 25
4.1 Induction of NASH 25
4.2 Molecular Probes 26
4.3 Operation Procedures 28
4.4 Laser and Microscope 30
Chapter 5 Discussion and Conclusion 33
5.1 Image Processing 33
Reference 39

1. Lai, S. W., Tan, C. K. & Ng, K. C. Epidemiology of fatty liver in a hospital-based study in Taiwan. South.Med.J. 95, 1288-1292 (2002).
2. So, P. T. C., Dong, C. Y., Masters, B. R. & Berland, K. M. Two-photon excitation fluorescence microscopy. Annu Rev Biomed Eng 2, 399-429 (2000).
3. W.Boyd, R. Nonlinear Optics. third edn, (ELSEVIER).
4. Max Born, E. W. Principles of Optics, Electromagnetic theory of propagation, interference and diffraction of light. 7th edn, (2005).
5. Matteoni, C. A. et al. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 116, 1413-1419 (1999).
6. Assy, N., DeKaita, K., Mymin, D., Levi, C. & Minuk, G. Y. Fatty infiltration of the liver in hyperlipidemic patients. Hepatology 24, 744-744 (1996).
7. 〈www.patholoty.med.umich.edu/greensonlab/M2liverlecture.html〉(
8. Farrell, G., Hall, McCullough. Fatty Liver Disease-NASH and Related Disorders. (Blackwell).
9. Angulo, P. Medical progress - Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221-1231 (2002).
10. Flegal, K. M., Carroll, M. D., Kuczmarski, R. J. & Johnson, C. L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int. J. Obes. 22, 39-47 (1998).
11. Sahai, A., Malladi, P., Melin-Aldana, H., Green, R. M. & Whitington, P. F. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am. J. Physiol.-Gastroint. Liver Physiol. 287, G264-G273, doi:10.1152/ajpgi.00002.2004 (2004).
12. Weltman, M. D., Farrell, G. C. & Liddle, C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111, 1645-1653 (1996).
13. McCuskey, R. S. et al. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 40, 386-393, doi:10.1002/hep.20302 (2004).
14. Cantz, T., Nies, A. T., Brom, M., Hofmann, A. F. & Keppler, D. MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells. Am. J. Physiol.-Gastroint. Liver Physiol. 278, G522-G531 (2000).
15. Liu, Y. et al. Visualization of hepatobiliary excretory function by intravital multiphoton microscopy. J Biomed Opt 12, 014014 (2007).
16. Lickteig, A. J. et al. Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease. Drug Metab. Dispos. 35, 1970-1978, doi:10.1124/dmd.107.015107 (2007).